Drug comparisons
Fremanezumab vs Methysergide
Fremanezumab vs Methysergide for migraine: Ajovy CGRP mAb vs ergot. Safer modern option vs outdated drug with fibrosis risk.
No comparison dimensions are available for this page.
Clinical context
Patients or clinicians comparing current CGRP-targeted therapies to historical ergot-based treatments for chronic migraine management.
Bottom line
Fremanezumab is generally the better choice for migraine prevention due to its efficacy and safety compared to Methysergide.
All medication comparisons